1. Gautier A, Godbout A, Grosheny C, Tejedor I, Coudert M, Courtillot C, Jublanc C, De Kerdanet M, Poirier JY, Riffaud L, Sainte-Rose C, Van Effenterre R, Brassier G, Bonnet F, Touraine P; on behalf of the Craniopharyngioma Study Group: Markers of Recurrence and Long-Term Morbidity in Craniopharyngioma: A Systematic Analysis of 171 Patients. J Clin Endocrinol Metab. 2012 97:1258-1267.
2. M Bidet, A Bachelot, E Bissauge, JL Golmard, S Gricourt, J Dulon, C Coussieu, Y Badachi, P Touraine. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab, 2011, 96:3864-72.
3. Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum Mutat. 2011, 32:1108-13
4. Achard C, Courtillot C, Lahuna O, Meduri G, Schumacher M, Liere P, Kuttenn F, Touraine P, Misrahi M (co-dernier auteur à part égale). Normal Spermatogenesis in a Man with Mutant Luteinizing Hormone. N Engl J Med. 2009, 361:1856-1863
5. Carine Courtillot, Zeina Chakhtoura, Roman Bogorad, Catherine Genestie, Sophie Bernichtein, Yasmina Badachi, Gilbert Janaud, Jean-Pierre Akakpo, Anne Bachelot, Frédérique Kuttenn, Vincent Goffin, Philippe Touraine on behalf of the Benign Breast Diseases Study Group. Characterization of two constitutively active prolactin receptor variants in a cohort of 95 women with multiple breast fibroadenomas, JCE&M, 2010 95:1182-90
6. Bidet M, Bellanné-Chantelot C, Galand-Portier MB, Tardy V, Billaud L, Laborde K, Coussieu C, Morel Y, Vaury C, Golmard JL, Claustre A, Mornet E, Chakhtoura Z, Mowszowicz I, Bachelot A, Touraine P, Kuttenn F. Clinical and molecular characterization of a cohort of 161 unrelated women with Nonclassical Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency and 330 family members. 2009 J Clin Endocrinol Metab. 94, 1570-8
7. Bachelot A, Rouxel A, Massin N, Dulon J, Courtillot C, Matuchansky C, Badachi Y, Fortin A, Paniel B, Lecuru F, Lefrère-Belda MA, Constancis E, Thibault E, Meduri G, Mantel A, Misrahi M, Kuttenn F, Touraine P, on behalf of the POF-GIS Study Group: Diagnosis strategy in 357 consecutive patients presenting a Premature Ovarian Failure; 2009 Eur J Endocrinol May 1. [Epub ahead of print]
8. Bogorad R, Courtillot C, Mestayer C, Harutyunyan L, Jomain JB, Bachelot A, Bernichtein S, Kuttenn F, Kelly PA, Goffin V, Touraine P, on behalf of the benign Breast Diseases Study Group. Gain of Function mutation of the prolactin receptor in women with benign breast tumors. 2008 PNAS, 105:14533-8.
9. Chakhtoura Z, Bachelot A, Samara-Boustani D, Ruiz JC, Donadille B, Dulon J, Christin-Maître S, Bouvattier C, Raux-Demay MC, Bouchard P, Carel JC, Leger J, Kuttenn F, Polak M, Touraine P. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency 2008 Eur J Endocrinol, 158:879-87
10. Meduri G, Massin N, Guibourdenche J, Bachelot A, Fiori O, Kuttenn F, Misrahi M, Touraine P. Serum AntiMullerian Hormone expression in women with premature ovarian failure 2007 Hum Reprod 1, 117-123
11. Goffin V, Touraine P, Culler MD, Kelly PA. Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? 2006 Nat Clin Pract Endocrinol Metab 10:571-81.
12. Goffin V, Bernichtein S, Touraine P, Kelly PA. Development and potential clinical uses of human prolactin receptor antagonists 2005 Endocr Rev, 26:400-22.